Clinical bottom line
Artificial intelligence (AI) models are emerging as promising tools to predict the risk of postoperative endophthalmitis following cataract surgery by integrating multiple clinical and surgical variables. These predictive algorithms may enhance risk stratification beyond traditional clinical risk factors, potentially enabling tailored prophylactic strategies. However, current evidence remains preliminary, and AI-based risk prediction requires further validation in diverse populations before routine clinical adoption.
What the evidence shows
Postoperative endophthalmitis is a rare but severe complication of cataract surgery, with incidence rates reported between 0.03% and 0.2% depending on surgical setting and prophylactic measures (Penman et al., 2020; ESCRS Study Group, 2007). Established risk factors include intraoperative complications, wound leaks, and inadequate antibiotic prophylaxis (Arshinoff et al., 2020; Bhopi et al., 2004). Traditional risk assessment relies on these clinical parameters, but their predictive accuracy is limited.
Recent advances in AI have enabled the development of predictive models that analyze large datasets incorporating patient demographics, comorbidities, surgical details, and perioperative management variables. These models use machine learning algorithms to identify complex, nonlinear interactions among risk factors that may be missed by conventional analyses. For example, AI approaches have shown potential to stratify patients into low- and high-risk categories for endophthalmitis, facilitating personalized prophylaxis and closer postoperative monitoring.
Although specific AI models for endophthalmitis risk prediction are not yet widely published in peer-reviewed literature, the rationale builds on extensive epidemiological data and risk factor analyses from large multicenter studies such as the ESCRS trial (2007) and national registries (Japanese Prospective Multicenter Study, 2017). These datasets provide the foundation for training and validating AI algorithms. Moreover, recent reports from high-volume centers, including Takeo Eye Hospital in Cambodia, highlight the ongoing need for improved risk stratification tools in diverse clinical environments (HENG et al., 2024).
Caveats and uncertainty
Despite the theoretical advantages, AI-based prediction of postoperative endophthalmitis remains largely investigational. Key limitations include:
- Data heterogeneity and quality: AI models require large, high-quality datasets with standardized variables. Variability in surgical techniques, antibiotic protocols, and patient populations may limit model generalizability.
- Low event rate: The rarity of endophthalmitis challenges model training and validation, increasing the risk of overfitting and false-positive predictions.
- Lack of prospective validation: Most AI models have not undergone prospective clinical trials to demonstrate improved patient outcomes or cost-effectiveness compared to standard risk assessment.
- Integration into clinical workflow: Practical implementation requires user-friendly interfaces and clinician acceptance, which remain to be established.
Until these challenges are addressed, AI predictions should be considered hypothesis-generating and adjunctive rather than definitive.
How this may change practice
If validated, AI-driven risk prediction tools could transform cataract surgery prophylaxis by enabling:
- Personalized prophylactic regimens: Tailoring antibiotic choice, dosing, and duration based on individualized risk profiles rather than uniform protocols.
- Targeted patient counseling: Informing patients about their specific risk and expected outcomes to guide shared decision-making.
- Optimized resource allocation: Focusing intensive postoperative surveillance and interventions on high-risk patients to improve safety and reduce costs.
- Quality improvement: Identifying modifiable risk factors through AI analysis may inform surgical technique refinements and perioperative care enhancements.
Clinicians should remain informed about ongoing developments in AI applications for endophthalmitis risk and critically appraise emerging evidence before integrating these tools into routine practice.